| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8776454 | Urology | 2017 | 19 Pages |
Abstract
Our observations potentially indicate activation (or inhibition) of specific signaling pathways in the lower urinary tract during chronic exposure to exogenous cannabinoids. Our study provides initial proteomic knowledge for future investigations on the potential role of exocannabinoids in the development of intravesical therapies to treat lower urinary tract disorders.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Balachandar Nedumaran, Pratyaydipta Rudra, Jeanette Gaydos, Sushil Kumar, Randall B. Meacham, Ellen L. Burnham, Anna P. Malykhina,